Comparison of Ultraviolet A1 and narrowband ultraviolet B phototherapy in prurigos

Not Applicable

Recruiting

• Conditions: Patients with prurigo nodularis; Prurigo nodularis, Phototherapy

• Registration Number: TCTR20170531002
• Lead Sponsor: Department of dermatology, Siriraj Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-05-31
• Study Completion: 2017-08-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

1.Recalcitrant prurigo nodularis patients for topical or systemic treatment more than 3 months.
2.Stopping topical therapy other than emollients within the
previous 2 weeks.
3.Stopping systemic immunomodulating or immunosuppressive
therapy within the last 1 month.
4.No history skin cancer.

Exclusion Criteria

1.Pregnancy
2.Patients with manifestations of underlying renal ⁄ hepatic ⁄
internal diseases or malignancy
3.History of photosensitivity

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the efficacy of UVA1 compared with NB-UVB phototherapy in patients with PN. 5 months Photographs, EASI score, Number of papules/nodules, Pruritus (visual analogue scale)

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A